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Photoageing resulting from long term exposure of the skin to UV light can beminimized by scavenging the reactive photochemical
intermediates with antioxidants. For effective photoprotection, the antioxidantmust overcome the barrier properties of the skin and
reach the target site in significant amounts. The present study aims to improve the skin penetration of caffeic acid, a very effective
free radical scavenger, by encapsulating in liposomes. Caffeic acid loaded liposomes prepared using the reverse phase evaporation
technique showed 70% encapsulation efficiency and size around 100 nm with zeta potential of −55mV. In vitro diffusion through a
dialysis membrane enabled 70% release of encapsulated caffeic acid within 7 h, whereas 95% of free caffeic acid diffused within 4 h
in PBS solution (pH 7.4). Liposomal caffeic acid permeation through pig skin epidermis in a Franz cell apparatus was 45 % during
7 h. In contrast, free caffeic acid was almost nonpermeable (<5%) to pig skin during this time. The DPPH assay indicated that skin
penetration did not destroy the antioxidant activity of liposomal caffeic acid or free caffeic acid. In conclusion, we confirm that
liposomal caffeic acid may be successfully employed as an effective photoprotective agent against UV mediated skin damage.
1. Introduction
The exposure of skin to solar ultraviolet (UV) radiation
causes skin damage resulting in both skin lesions and acceler-
ation of skin ageing [1].TheUVB radiation preferentially acts
on epidermis where it damages DNA in keratinocytes, while
UVA is able to penetrate far deeper into the skin and hence
exerts effects on both dermal and epidermal parts of the skin
[2]. Further, the UV radiation causes the depletion of natural
cellular antioxidants such as vitamins A, C, and E, squalene,
and coenzyme Q-10 resulting in the accumulation of reactive
oxygen species (ROS): hydrogen peroxide, superoxide anion,
singlet oxygen, hydroxyl radicals, and nitric oxide (NO)
[3]. This imbalance between the production of ROS and
reduction of antioxidant defences leads to cellular damage
which disrupts the structural integrity of the skin thereby
accelerating the ageing process [2]. The antioxidants react
with and prevent formation of undesirable free radicals
during the oxidation processes. Topical administration of
antioxidants has been proved as a successful remedy for
protecting the skin against UV mediated oxidative damage
[4]. Caffeic acid (3,4-dihydroxycinnamic acid) is a hydrox-
ycinnamic acid which is the major subgroup of phenolic
compounds. These are secondary plant metabolites naturally
produced in almost all plants as key intermediates in the
biosynthesis of lignin. Caffeic acid can be isolated from
the bark of Eucalyptus globulus Labill. [5]. In plants, it is
biosynthesized from 4-hydroxycinnamic acid [6] and can be
transformed into ferulic acid.These types of phenolics exhibit
strong antioxidant activity.
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Caffeic acid is known to be an effective antioxidant in
different in vitro antioxidant assays such as 1,1-diphenyl-2-
picryl-hydrazyl (DPPH) free radical scavenging, 2,2󸀠-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical
scavenging, total antioxidant activity by ferric thiocyanate
method, reducing power, and superoxide anion radical
scavenging [7]. Caffeic acid and its derivatives can trap
the free radicals directly or scavenge them through several
coupled reactions [8]. Different approaches have been used
to maximize the performance of these antioxidants because
proper absorption into the skin and appropriate residence
time at the target tissue are required to obtain the desired
outcome [9].
However, themain obstacle to these topical applications is
the blocking nature of the skin which prevents permeation of
the reactive agent.The penetration ofmost drugs through the
stratum corneum of the skin is more slow [10].Thus, topically
applied drugs are modified with a carrier system to allow
penetration through the stratum corneum. Among various
strategies followed to improve the efficacy of bioactive agents,
liposomes figure importantly. Liposomes are composed of
one or more lipid bilayers surrounding an equal number of
aqueous compartments created from cholesterol and natural
nontoxic lipids [11]. More importantly, liposomes are able
to solubilize lipid molecules in their lipid bilayer as well
as hydrophilic molecules in its aqueous core [12], such that
the incorporated molecules receive protection within the
liposomes [11], at the same time acting as drug reservoirs
for slow drug release [13]. Though the liposomal mechanism
of action is not fully understood, researches have proved
enhanced topical delivery of liposomal bioactive agents. For
example, a liposomal catechin formulation provided better
efficiency of catechin delivery with limited skin disruption
and good stability [14]. There are several studies based on
ferulic acid (a hydroxycinnamic acid) loaded liposomes for
improved efficacy. A study on the entrapment of ferulic
acid in liposomes resulted in high solubility and improved
biodistribution of ferulic acid [15].
In the work described, caffeic acid was incorporated in
liposomes with a view of improving its topical delivery. Slow
release, the influence of liposomes on the skin permeation,
and the influence of liposomes on the antioxidant activity of
caffeic acid were investigated.
2. Materials and Methods
2.1. Materials. Caffeic acid (98%), cholesterol (99%), egg
phosphatidylcholine (99%), sodium chloride, potassium
chloride, potassium dihydrogen phosphate, and disodium
hydrogen phosphate were purchased from Sigma-Aldrich
Chemical Company (St. Louis, MO, USA). Methanol, chlo-
roform, diethyl ether, ethanol, and acetone were of analytical
grade. The adult pig ear was obtained from a local slaughter
house. Snake skin dialysis tubing with a MW cut-off of 3500
was purchased fromThermo Scientific, USA.
Ethical clearance was granted by the Postgraduate Insti-
tute of Science, University of Peradeniya, Peradeniya, Sri
Lanka.
2.2. Preparation of Caffeic Acid Loaded Liposomes. Caffeic
acid encapsulated liposomes were prepared using the reverse
phase evaporationmethod adapted from literature [16]. First,
the lipid components, egg phosphatidylcholine (2%, w/v),
cholesterol (0.8%, w/v), and caffeic acid (0.02%, w/v), were
dissolved in 5.0mL volume of a chloroform :methanol (2 : 1)
mixture. Next, the solvent was evaporated using a rotary
evaporator at 40∘C. Then, the lipid film was redissolved in
the organic layer (diethyl ether). Then, 10.0mL of 0.01M
phosphate buffered saline (PBS) solution (pH 7.4) was added
and the mixture was sonicated for 5–10 minutes in a bath
type sonicator (Ultrasonic Bath, Grant). The organic solvent
in the mixture was removed using a rotary evaporator, and
another 5.0mL of 0.01M PBS (pH 7.4) was added and
allowed to equilibrate at room temperature. Finally, the
nonencapsulated caffeic acid was separated by centrifugation
immediately after liposome preparation at 16000 rpm (Sigma
3-18, Laborzentrifugen, Germany) to obtain the caffeic acid
loaded liposomes.
2.3. Determination of Encapsulation Efficiency. Encapsula-
tion efficiency of caffeic acid encapsulated liposomes was
determined using spectrophotometry. The absorbance of
caffeic acid remaining in the supernatant after centrifugation
was measured at 285 nm using the UV-Visible spectropho-
tometer (Shimadzu, UV-3600, UV-VIS-NIR, Japan). Then,
the concentration was calculated from a calibration plot
obtained for pure caffeic acid. Encapsulation efficiency was
calculated as follows:
Encapsulation efficiency =
𝑇
𝑐
− 𝑇
𝑠
𝑇
𝑐
× 100, (1)
where𝑇
𝑐
is the total caffeic acid used and𝑇
𝑠
is the total caffeic
acid present in the supernatant.
2.4. Determination of Particle Size and Zeta Potential of
Caffeic Acid Loaded Liposomes. The average particle size and
size polydispersity of the liposomes dispersed in PBS after
centrifugation were determined by dynamic light scattering
technique at 25∘C using a particle size analyzer (Zetasizer
Nano ZS, Malvern Instruments, UK) at a fixed scattering
angle of 90∘.The zeta potential of nanoparticles wasmeasured
using the zeta potential analyzer (ZetasizerNanoZS,Malvern
Instruments, UK). All measurements were performed in
triplicate.
For time dependent changes the average particle size
and zeta potential of the samples of liposomes stored in the
dispersed forms at 4∘C were measured after one month and
two months.
2.5. Analysis of the Liposomal Morphology. Liposomal mor-
phologywas also examined by ScanningElectronMicroscopy
(SEM, SU6600, Hitachi, Japan) operating at 5 and 10 kV. A
drop of the particle suspension was placed on a clean glass
slide coated with poly-l-lysine and dried well. The dried
specimen was subjected to gold sputtering and observed by
SEM.
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2.6. In Vitro Release Study. The release characteristics of
caffeic acid from liposomes were studied in PBS solution
(pH∼7.4) at 37∘C. 5mL of caffeic acid loaded liposomes
(135 ppm of caffeic acid) was trapped inside a snake skin
dialysismembrane (MWcut-off 3500) and thiswas immersed
in PBS (25.0mL) at room temperature under mild agitation.
Aliquots (1.5mL) were withdrawn at predetermined time
intervals andmixed well with 1.5mL of 0.1Mmethanol. Next,
the UV absorbance was recorded at 285 nm using the UV-
Visible spectrophotometer.The releasemediumwas refreshed
with 1.5mL of medium after each withdrawal. All measure-
mentswere performed in triplicate.Using the calibration plot,
the concentrations were calculated and hence the cumulative
release percentages were determined.
Similarly, a diffusion study of free caffeic acid (5mL of
135 ppm) with a concentration similar to the encapsulated
liposomal caffeic acid was carried out using the above
procedure.
2.7. ExVivo Skin Permeation Study. Thepig earwas separated
from the cartilage using a scalpel and forceps and the fat
layer was removed, without disturbing the hair follicles, to
expose the epidermis. Then, a skin disk was punched and
immersed in the acceptormedium (PBS pH 7.4) to equilibrate
until used. Next, the skin disk was placed on a filter paper
to remove the surface solution and fixed between donor and
acceptor areaswith the stratum corneum side up.Theavailable
surface area of the skin for permeation was 1.76 cm2. The
donor compartment contained 2.5mL of liposomal caffeic
acid and the receiver compartment 10mL of PBS (pH 7.4).
The temperature was maintained at 37∘C by immersing the
diffusion cell in a water bath. The receiver compartment
was magnetically stirred at 300 rpm. Aliquots (1.0mL) were
removed from the receptor compartment at 1-hour intervals
and refreshed with 1.0mL of PBS solution. This was repeated
during a period of 7 hours. After the experiment, the pig ear
skin was removed from the setup and soaked in methanol
well and checked for the skin deposited caffeic acid. Same
procedure was repeated with a similar concentration of free
caffeic acid as the liposomal caffeic acid. All experiments were
done in triplicate.
Quantification of Caffeic Acid in Collected Aliquots. Fresh PBS
(1.0mL) and 0.1M methanol (2.0mL) were added to each
aliquot collected and mixed well. Then, the absorbance of
each aliquot was measured at 285 nm using the UV-Visible
spectrophotometer.The concentrationswere calculated using
a calibration plot and the cumulative skin permeation per-
centages were determined.
Calculation of Cumulative Drug Permeation (𝑄), Flux (𝐽), and
Permeation Coefficient (𝐾
𝑝
). The average steady state flux (𝐽)
is given by the following equation:
𝐽 =
𝑑𝑄
𝑑𝑡
1
𝐴
,
(2)
where 𝐴 is surface area of the skin and 𝑑𝑄/𝑑𝑡 is the slope of
the plot of 𝑄 versus 𝑡.
The skin permeability coefficient (𝐾
𝑝
) is given by the
equation
𝐾
𝑝
=
J
ΔC
,
(3)
whereΔ𝐶 is drug concentration difference between the donor
and the receptor at a given time.
The average permeability coefficient can be calculated
using the equation
(𝐾
𝑝
) ave = ∑ (𝐽/Δ𝐶)
𝑁
,
(4)
where𝑁 is number of intervals.
2.8. Determination of In Vitro Antioxidant Activity of Encap-
sulated Caffeic Acid. To determine the activity of liposomal
caffeic acid after permeation through the dialysis membrane
and pig ear skin, the following experiment was performed.
Briefly, 2.5mL from the release medium after 7 h of in vitro
release experiment of caffeic acid loaded liposomes through
dialysis membrane and pig ear skin was added separately
to 0.6mM DPPH in methanol (0.5mL) and topped up
to 5.0mL with methanol. This reaction mixture was kept
in the dark for 30 minutes and then the absorbance was
measured at 514 nm using the UV-Visible spectrophotometer.
DPPH in methanol was used as the control. DPPH assay was
performed according to the procedure described by Braca
et al. [17]. The antioxidant activity of a standard solution of
caffeic acid of similar concentration of caffeic acid obtained
from the release media after 7 h of permeation experiments
through dialysis membrane and pig ear skin, respectively,
was measured and compared with the antioxidant activity
of permeated caffeic acid in both experiments. The DPPH
radical scavenging activity was calculated using the following
formula:
DPPH radical scavenging activity (%)
= (
𝐴
𝑐
− 𝐴
𝑠
𝐴
𝑐
) × 100,
(5)
where 𝐴
𝑐
is the absorbance of the control and 𝐴
𝑠
is the
absorbance of the sample.
3. Results and Discussion
3.1. Characterization of Caffeic Acid Loaded Liposomes. The
macroscopic appearance of the liposomal suspension was
milky with a slight yellowish reflection characteristic of
nanometric suspensions [18]. Caffeic acid loaded liposomes
were characterized for their size, zeta potential, encapsulation
efficiency, and morphology. The size, zeta potential, and
encapsulation efficiency of nanoparticles were tabulated in
Table 1. The average size of unloaded liposomes obtained
from the dynamic light scattering technique was around
100 nm and the size distribution graph showed a Gaussian
distribution of sizes of around 80–120 nm. This observation
strongly supports the claim that liposomes within the size
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Table 1: The size, zeta potential, and % EE of unloaded liposomes and caffeic acid loaded liposomes (each value represents the mean ± SD,
𝑛 = 3).
System Average size/nm Zeta potential/mV % encapsulation efficiency
Unloaded liposomes 100 ± 27 −40 ± 3 —
Caffeic acid loaded liposomes 100 ± 35 −55 ± 4 70 ± 4
Table 2: Timedependent changes in the size and zeta potential of caffeic acid loaded liposomes andunloaded liposomes (each value represents
the mean ± SD, 𝑛 = 3).
Systems Average size/nm Zeta potential/mV
0 months 1 month 2 months 0 months 1 month 2 months
Unloaded liposomes 100 ± 27 112 ± 23 110 ± 31 −40 ± 3 −42 ± 5 −44 ± 7
Caffeic acid loaded liposomes 100 ± 35 104 ± 34 108 ± 28 −55 ± 4 −52 ± 6 −49 ± 4
range of 25–100 nm are small unilamellar type vesicles [19].
According to du Plessis et al., the intermediate sized lipo-
somes (100–200 nm) show a better skin penetration suggest-
ing the size dependence of liposomes in topical delivery [20].
So the liposomes we obtained might have a favourable effect
on skin penetration.
The high negative zeta potential of the loaded liposomes
(−55mV) is attributed to caffeic acid being a negatively
charged molecule. Zeta potential is a good index of the
magnitude of repulsive interactions between colloidal par-
ticles and it is commonly used to assess the stability of
a nanosuspension. A high positive or negative value for
zeta potential indicates that the repulsion between particles
is high; hence, the colloidal dispersion would show good
stability.
The liposomes obtained from reverse phase evaporation
technique showed relatively high encapsulation efficiency
of 70%. The reverse phase evaporation technique is more
suitable since the encapsulant, caffeic acid, is poorly water
soluble and also this technique results in high encapsulation
efficiencies [16]. According to Caddeo et al., generally, lipo-
somal encapsulation was not significantly influenced by the
lipid composition [21]. This high encapsulation efficiency is
related to the poor water solubility of caffeic acid whichmight
incorporate entirely with lipid bilayer by this technique.
In the stability testing, a significant difference in the
average sizes as well as in the zeta potentials of unloaded
liposomes and caffeic acid liposomes could not be observed
(Table 2). After one month, the average size and the zeta
potential of unloaded liposomes were 112 ± 23 nm and
−42 ± 5mV, respectively, whereas with the caffeic acid loaded
liposomes thesewere 104±34 nmand−52±4mV, respectively.
After two months’ time period also not any noticeable
difference in average sizes of both systems was observed
(Table 2). Though a slight drop with the zeta potential of
caffeic acid loaded liposomes (−49±4mV)was observed, still
the parameters indicate a stable colloidal suspension. This is
in accordance with a previously published study on sodium
ascorbyl phosphate loaded liposomes [22].
Morphological analysis of these liposomes by SEM
showed spherical shaped 3D globular vesicles (Figure 1).
Figure 1: SEM image of caffeic acid loaded liposomes.
3.2. In Vitro Release Studies of Caffeic Acid Loaded Liposomes.
In order to obtain qualitative and quantitative information,
the release properties of liposomal caffeic acid and free caffeic
acid were determined in PBS solution (pH 7.4). In this study
using the dialysis membrane method, kinetics showed an
initial burst release of liposomal caffeic acid of 45% within
2 h of diffusion which was considered important for attaining
higher levels of caffeic acid for skin penetration (Figure 2(b)).
A continuous increase in the cumulative release up to 71%
could be observed in the following 2 to 6 h. After 24 h,
only a 1% increment in the cumulative release amount was
attained. The remaining 30% of liposomal caffeic acid might
be permanently trapped inside the liposomes. When release
of liposomal caffeic acid in the experiment above is compared
to the release of free caffeic acid, a clear difference could
be observed. Free caffeic acid diffuses rapidly where almost
50% had diffused after 2 h. Within 4 h, 95% of the free caffeic
acid permeated through the dialysis membrane (Figure 2(a)),
indicating that liposomal encapsulation enables slow release
up to 7 h.This observation is further supported by the study of
Focˇo et al., who investigated liposomes as carriers of sodium
ascorbyl phosphate for cutaneous photoprotection. Their in
vitro diffusion study was performed in PBS with cellulose
membrane and they reported 80%of liposomal release within
8 h [22].
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Table 3: Permeability results obtained for free caffeic acid and liposomal caffeic acid for the permeation through pig ear epidermis.
Formulation Study period (h) Percent skin permeation (%) Percent skin deposition (%) 𝐾
𝑝
average (10−3 cmmin−1)
Free caffeic acid 7 5.3 ± 1.91 6.38 ± 3.10 1.33
Liposomal caffeic acid 7 41.8 ± 1.58 2.0 ± 0.02 28.19
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Figure 2: In vitro cumulative release profiles of (a) free caffeic
acid and (b) liposomal caffeic acid through dialysis membrane at
predetermined time intervals in pH 7.4 PBS. Data points represent
mean cumulative release (±SD) calculated from 3 samples.
3.3. Ex Vivo Skin Permeability Study. Considering the
slow release of caffeic acid from liposomes, the effect of
liposomal caffeic acid on skin permeation was studied. The
percutaneous penetration of liposomal caffeic acid and free
caffeic acid was compared using a Franz cell. The aim of this
study was to determine whether the encapsulated caffeic acid
has an improvement in permeation through the epidermis.
According to the permeation profile for liposomal caffeic acid
(Figure 3(a)), a considerable amount of caffeic acid (41.8 ±
1.58%) had permeated slowly through the epidermis during
7 h while only 2.0 ± 0.02% of caffeic acid had deposited in
the skin. The standard errors among some cumulative skin
permeation values (2–5 h) were higher probably due to the
differences among skin donors in the triplicate study. Free
caffeic acid penetration was 5.3 ± 1.91% (Figure 3(b)), which
is significantly lower than liposomal caffeic acid, whereas the
skin deposition of free caffeic acid was 6.38 ± 3.10% which
is slightly higher than the deposition of liposomal caffeic
acid. Liposomal caffeic acid permeation was almost eight
times higher than the amount of free caffeic acid penetrated
through the epidermis (Table 3). This is further corroborated
by the values obtained for the average permeation coefficient
(𝐾
𝑝
average) in Table 3. The highest average permeability
(𝐾
𝑝
average = 28.19× 10−3 cmmin−1) for pig earwas obtained
with liposomal caffeic acid whereas the average permeation
coefficient for free caffeic acid was 1.33 × 10−3 cmmin−1
indicating poor skin permeation of free caffeic acid through
pig ear epidermis.
The interaction between skin and liposomes themselves
may be an important contributory factor for this increase in
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Figure 3: Ex vivo penetration profiles of (a) liposomal caffeic acid
and (b) free caffeic acid through pig ear epidermis at predetermined
time intervals in pH 7.4 PBS. Data points representmean cumulative
release (±SD) calculated from 3 samples.
penetration of caffeic acid. Phosphatidylcholine may serve as
a skin penetration enhancer interacting with and hydrating
the stratum corneum, facilitating the penetration of liposo-
mal encapsulants [23]. Free caffeic acid which showed 95%
diffusion through the dialysis membrane could only show
5% penetration of the pig skin. This might be due to the
lower barrier effect of the dialysis membrane compared to the
complex pig ear skin. The dialysis membrane is composed of
cellulose while the skin is a complex lipid bilayer membrane.
The cumulative liposomal caffeic acid percentage permeated
through pig skin warrants further studies. For example, the
skin penetration of liposomal sodium ascorbyl phosphate
was around 50% after 8 h [22] which compares well with
our study. In addition, several studies have confirmed that
the amount of penetrated compound was significantly higher
from liposomal formulations than from aqueous solution [3].
Therefore, encapsulation in liposomes would improve topical
delivery of caffeic acid through the skin.
3.4. In Vitro Antioxidant Activity. The in vitro antioxidant
activity of liposomal caffeic acid after the dialysis membrane
and skin permeation experiments was determined by the
DPPH free radical scavenging assay. From this method it is
possible to determine the antioxidant power of an organic
compound by measuring the decrease in absorbance of
DPPH radical. The dialysis membrane permeated liposomal
caffeic acid after 7 h showed 83.36 ± 1.62% of free radical
scavenging activity whereas standard caffeic acid at the same
concentration was 86.18 ± 1.50% (Figure 4). Similarly, the
antioxidant activity of liposomal caffeic acid permeated after
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Figure 4: A comparison of percent antioxidant activity of liposomal
caffeic acid after membrane permeation with that of the standard
caffeic acid. Results are represented as the mean ± SD of three
experiments.
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Figure 5: A comparison of percent antioxidant activity of liposomal
caffeic acid after pig ear epidermis permeation with that of the
standard caffeic acid. Results are represented as the mean ± SD of
three experiments.
7 h of skin permeation experiment was 51.07 ± 11.68%
while the caffeic acid standard of same concentration had an
activity of 56.66 ± 3.21% (Figure 5). Clearly, encapsulation
with liposomes does not destroy the antioxidant activity of
caffeic acid permeating through the two types of membranes.
These values further reflect the amount of caffeic acid pene-
trating through the dialysis membrane (71%) and the pig skin
(41.8%).
4. Conclusion
Caffeic acid loaded liposomes with high encapsulation effi-
ciency (70%) and of average size of 100 nm and high negative
zeta potential −55mV were prepared. These liposomes were
able to achieve a cumulative release of 71% of entrapped
caffeic acid within 7 h in PBS solution (pH 7.4). The results
of the pig ear epidermal membrane experiment proved the
enhanced penetration of liposomal caffeic acid in comparison
to free caffeic acid applied to the skin surface, suggesting
it as a potential delivery system for the antioxidant caffeic
acid. There was neither a reduction nor a synergic effect on
the antioxidant activity of caffeic acid after encapsulation in
liposomes, but the original activity was retained. The data
from this study support the claim that liposomal encapsula-
tion could improve the penetration of caffeic acid through the
epidermis which could reduce the photodamage to the skin.
Further, this formulation has the feasibility of developing
as a skin cream formulation to successfully slow down the
complex process of photooxidative skin damage.
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